Carmell rebrands to Longevity Health (XAGE); guides FY25 rev $3-4M; names Vice Chairman

Longevity Health Holdings, Inc.

Name change to Longevity Health Holdings effective March 5; tickers to XAGE/XAGEW March 10.
Patrick Sturgeon appointed Vice Chairman; previously CFO and board director since July 2023.
Combined sales grew 34% in Jan-Feb 2025 vs 2024 post Elevai acquisition.
Elevai's post-acquisition burn rate reduced >50% via overhead cost synergies.
FY25 revenue guidance $3-4M; Q2 2025 product launches include hair growth serum, soapless facial cleanser, etc.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.